Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.1K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

694
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
694
Neural Regulation01:37

Neural Regulation

41.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
41.1K
Brainstem01:19

Brainstem

4.1K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
4.1K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.2K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.2K
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

735
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
735

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Cortical Correlates of Gait Compensation Strategies in Parkinson Disease.

Annals of neurology·2022
Same author

Does Ethnicity Influence Recruitment into Clinical Trials of Parkinson's Disease?

Journal of Parkinson's disease·2022
Same author

Dairy Intake and Parkinson's Disease: A Mendelian Randomization Study.

Movement disorders : official journal of the Movement Disorder Society·2022
Same author

Aerobic Exercise Alters Brain Function and Structure in Parkinson's Disease: A Randomized Controlled Trial.

Annals of neurology·2021
Same author

Rapid Dynamic Naturalistic Monitoring of Bradykinesia in Parkinson's Disease Using a Wrist-Worn Accelerometer.

Sensors (Basel, Switzerland)·2021
Same author

Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach.

NPJ Parkinson's disease·2021
Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026
Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026
Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026
Same journal

Documenting hospice care.

Lancet (London, England)·2026
Same journal

After the wood chipper.

Lancet (London, England)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: Nov 9, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.9K

パーキンソン病

Bastiaan R Bloem1, Michael S Okun2, Christine Klein3

  • 1Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Centre of Expertise for Parkinson and Movement Disorders, Nijmegen, Netherlands.

Lancet (London, England)
|April 13, 2021
PubMed
まとめ
この要約は機械生成です。

パーキンソン病は 神経退行性疾患で 原因と症状は複雑です パーソナライズされた管理と多学科ケアが 鍵となるのですが 現在の治療法では 症状が治るのではなく 進行するだけです

さらに関連する動画

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.1K
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

18.5K

関連する実験動画

Last Updated: Nov 9, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.9K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.1K
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

18.5K

科学分野:

  • 神経学
  • 神経変性疾患
  • 遺伝学

背景:

  • パーキンソン病 (PD) は複雑な神経変性疾患で,世界的な流行が増加しています.
  • PDの症例の3~5%は単一性ですが,遺伝的リスクには90の遺伝子変異が寄与しています.
  • 危険因子には家族歴,便秘,非喫煙者などがあり,それぞれがPDのリスクを倍増させる可能性があります.

研究 の 目的:

  • パーキンソン病の総合的な概要を 提供するためです
  • パーソナライズされた経営戦略の重要性を強調する.
  • 現在の診断基準,非運動症状,およびプロドロマの段階について議論します.

主な方法:

  • 静止状態の震えや硬さによるブラディキネシアによる臨床診断
  • 非運動症状を含む多面的な臨床表現の認識
  • 遺伝的要因,リスク関連,および予後カウンセリングのレビュー.

主要な成果:

  • 診断は臨床的な表象に依存し,補助的な検査は非典型的症例です.
  • 臨床的に発現するパーキンソン病の前には長いプロドロマ期間があります.
  • レボドーパは第一線の症状治療であり,多科目の治療を強調しています.

結論:

  • パーキンソン病の最適な管理には 個別化された多分野アプローチが必要です
  • 現在の治療法では病気の進行を止めることはできませんが,病気を修正する治療法に関する研究は進行中です.
  • 病気のサブタイプとプロドロマの段階を理解することは,将来の治療の進歩にとって極めて重要です.